The clinical value of whole blood point‐of‐care biomarkers in large animal emergency and critical care medicine. (15th January 2015)

• Record Type: Journal Article
• Authors: Radcliffe, Rolfe M.; Buchanan, Ben R.; Cook, Vanessa L.; Divers, Thomas J.
• Is Part Of: Journal of veterinary emergency and critical care. Volume 25:Number 1(2015:Jan./Feb.)
• Page Start: 138
• Page End: 151
• Publication Date: 2015-01-15
• Subjects: Veterinary emergencies -- Periodicals; Veterinary critical care -- Periodicals; 636.089
• DOI: 10.1111/vec.12276
• Languages: English
• ISSNs: 1479-3261

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="vec12276-sec-0010" sec-type="section"> <title>Objective</title> <p>To summarize the current medical literature and provide a clinical perspective of whole blood point‐of‐care (POC) biomarkers in large animal emergency and critical care practice.</p> </sec> <sec id="vec12276-sec-0020" sec-type="section"> <title>Data Sources</title> <p>Original studies, reviews, and textbook chapters in the human and veterinary medical fields.</p> </sec> <sec id="vec12276-sec-0030" sec-type="section"> <title>Summary</title> <p>POC biomarkers are tests used to monitor normal or disease processes at or near the patient. In both human and veterinary medicine these tools are playing an increasingly important role in the management of critical diseases. The most important whole blood POC biomarkers available for veterinary practitioners include <sc>l</sc>‐lactate, cardiac troponin I, serum amyloid A, triglyceride, creatinine, and glucose, although many other tests are available or on the horizon.</p> </sec> <sec id="vec12276-sec-0040" sec-type="section"> <title>Conclusion</title> <p>Whole blood POC biomarkers enable clinicians to provide improved management of critical diseases in large animals. These tools are especially useful for establishing a diagnosis, guiding therapy, and estimating disease risk and prognosis.</p> </sec> </abstract>